keyword
MENU ▼
Read by QxMD icon Read
search

Duvvuri

keyword
https://www.readbyqxmd.com/read/27850120/480-comparison-of-treatment-of-ketoacidosis-associated-with-sglt-2-inhibitors-and-usual-dka
#1
Padmaraj Duvvuri, Jeffery Spray, Marcia Brackbill, Abhijit Duggal
No abstract text is available yet for this article.
December 2016: Critical Care Medicine
https://www.readbyqxmd.com/read/27832205/gallstones-a-worldwide-multifaceted-disease-and-its-correlations-with-gallbladder-carcinoma
#2
Raj Kumar Sharma, Kanchan Sonkar, Neeraj Sinha, Pradeep Rebala, Ahmad Ebrah Albani, Anu Behari, Duvvuri Nageshwar Reddy, Alvina Farooqui, Vinay Kumar Kapoor
BACKGROUND: Gallstones (GS) associated diseases are among the most recurrent and frequent diseases delineated in India and United Arab Emirates. Several reports suggest that the association of GS with gallbladder cancer (GBC) is very high in Northern part of India; however, its occurrence in UAE and Southern part of India is notably low. Therefore, in the present study, we aimed to perform compositional analysis of GS in three different geographical areas by Solid State Nuclear Magnetic Resonance and Fourier Transformed Infrared spectroscopy...
2016: PloS One
https://www.readbyqxmd.com/read/27818599/progression-from-low-grade-dysplasia-to-malignancy-in-patients-with-barrett-s-esophagus-diagnosed-by-two-or-more-pathologists
#3
Harsha Moole, Jaymon Patel, Zohair Ahmed, Abhiram Duvvuri, Sreekar Vennelaganti, Vishnu Moole, Sowmya Dharmapuri, Raghuveer Boddireddy, Pratyusha Yedama, Naveen Bondalapati, Achuta Uppu, Prashanth Vennelaganti, Srinivas Puli
AIM: To evaluate annual incidence of low grade dysplasia (LGD) progression to high grade dysplasia (HGD) and/or esophageal adenocarcinoma (EAC) when diagnosis was made by two or more expert pathologists. METHODS: Studies evaluating the progression of LGD to HGD or EAC were included. The diagnosis of LGD must be made by consensus of two or more expert gastrointestinal pathologists. Articles were searched in Medline, Pubmed, and Embase. Pooled proportions were calculated using fixed and random effects model...
October 21, 2016: World Journal of Gastroenterology: WJG
https://www.readbyqxmd.com/read/27733374/phase-ii-trial-of-post-operative-radiotherapy-with-concurrent-cisplatin-plus-panitumumab-in-patients-with-high-risk-resected-head-and-neck-cancer
#4
R L Ferris, J L Geiger, S Trivedi, N C Schmitt, D E Heron, J T Johnson, S Kim, U Duvvuri, D A Clump, J E Bauman, J P Ohr, W E Gooding, A Argiris
BACKGROUND: Treatment intensification for resected, high-risk, head and neck squamous cell carcinoma (HNSCC) is an area of active investigation with novel adjuvant regimens under study. In this trial, the epidermal growth-factor receptor (EGFR) pathway was targeted using the IgG2 monoclonal antibody panitumumab in combination with cisplatin chemoradiotherapy (CRT) in high-risk, resected HNSCC. PATIENTS AND METHODS: Eligible patients included resected pathologic stage III or IVA squamous cell carcinoma of the oral cavity, larynx, hypopharynx, or human-papillomavirus (HPV)-negative oropharynx, without gross residual tumor, featuring high-risk factors (margins <1 mm, extracapsular extension, perineural or angiolymphatic invasion, or ≥2 positive lymph nodes)...
October 11, 2016: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://www.readbyqxmd.com/read/27688103/oncologic-outcomes-and-patient-reported-quality-of-life-in-patients-with-oropharyngeal-squamous-cell-carcinoma-treated-with-definitive-transoral-robotic-surgery-versus-definitive-chemoradiation
#5
D C Ling, B V Chapman, J Kim, G W Choby, P Kabolizadeh, D A Clump, R L Ferris, S Kim, S Beriwal, D E Heron, U Duvvuri
OBJECTIVE: It has been postulated that treatment outcomes are similar between transoral robotic surgery (TORS) and definitive chemoradiation (CRT) for oropharyngeal squamous cell carcinomas (OPSCC). We compared oncologic and quality of life (QOL) outcomes between definitive CRT and definitive TORS. MATERIALS AND METHODS: An observational comparison study was performed on 92 patients treated with TORS±adjuvant therapy and 46 patients treated with definitive CRT between July 2005 and January 2016...
October 2016: Oral Oncology
https://www.readbyqxmd.com/read/27675987/risk-of-severe-toxicity-based-on-site-of-recurrence-in-patients-treated-with-stereotactic-body-radiation-therapy-for-recurrent-head-and-neck-cancer
#6
D C Ling, J Vargo, R L Ferris, J Ohr, D A Clump, W Y W Yau, U Duvvuri, S Kim, J T Johnson, J E Bauman, B F Branstetter, D E Heron
No abstract text is available yet for this article.
October 1, 2016: International Journal of Radiation Oncology, Biology, Physics
https://www.readbyqxmd.com/read/27648439/endoscopic-versus-percutaneous-biliary-drainage-in-palliation-of-advanced-malignant-hilar-obstruction-a-meta-analysis-and-systematic-review
#7
REVIEW
Harsha Moole, Sirish Dharmapuri, Abhiram Duvvuri, Sowmya Dharmapuri, Raghuveer Boddireddy, Vishnu Moole, Prathyusha Yedama, Naveen Bondalapati, Achuta Uppu, Charan Yerasi
Background. Palliation in advanced unresectable hilar malignancies can be achieved by endoscopic (EBD) or percutaneous transhepatic biliary drainage (PTBD). It is unclear if one approach is superior to the other in this group of patients. Aims. Compare clinical outcomes of EBD versus PTBD. Methods. (i) Study Selection Criterion. Studies using PTBD and EBD for palliation of advanced unresectable hilar malignancies. (ii) Data Collection and Extraction. Articles were searched in Medline, PubMed, and Ovid journals...
2016: Canadian Journal of Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/27585358/metabolic-variations-in-normal-and-fibrotic-human-laryngotracheal-derived-fibroblasts-a-warburg-like-effect
#8
Garret Ma, Idris Samad, Kevin Motz, Linda X Yin, Madhavi V Duvvuri, Dacheng Ding, Daryan R Namba, Jennifer H Elisseeff, Maureen R Horton, Alexander T Hillel
OBJECTIVES/HYPOTHESIS: Laryngotracheal stenosis (LTS) is a chronic fibrotic disease characterized by fibroblast proliferation, collagen deposition, and matrix remodeling in the lamina propria of the larynx and/or trachea. Current medical therapies are limited by a poor understanding of the effector cell's (fibroblasts) cellular biology and metabolism. The purpose of this study was to compare cellular proliferation, function, and metabolism between normal and LTS-derived fibroblasts in vitro...
September 1, 2016: Laryngoscope
https://www.readbyqxmd.com/read/27531873/association-of-pretreatment-body-mass-index-and-survival-in-human-papillomavirus-positive-oropharyngeal-squamous-cell-carcinoma
#9
William G Albergotti, Kara S Davis, Shira Abberbock, Julie E Bauman, James Ohr, David A Clump, Dwight E Heron, Umamaheswar Duvvuri, Seungwon Kim, Jonas T Johnson, Robert L Ferris
BACKGROUND: Pretreatment body mass index (BMI) >25kg/m(2) is a positive prognostic factor in patients with head and neck cancer. Previous studies have not been adequately stratified by human papilloma virus (HPV) status or subsite. Our objective is to determine prognostic significance of pretreatment BMI on overall survival in HPV+ oropharyngeal squamous cell carcinoma (OPSCC). METHODS: This is a retrospective review of patients with HPV+ OPSCC treated between 8/1/2006 and 8/31/2014...
September 2016: Oral Oncology
https://www.readbyqxmd.com/read/27312369/a-description-of-the-anatomy-of-the-glossopharyngeal-nerve-as-encountered-in-transoral-surgery
#10
Chengyuan Wang, Summit Kundaria, Juan Fernandez-Miranda, Umamaheswar Duvvuri
OBJECTIVES/HYPOTHESIS: To illustrate detailed anatomy of the extracranial portion of the glossopharyngeal nerve in the parapharyngeal space as encountered during transoral surgery. STUDY DESIGN: Prospective cadaveric dissection. All dissections were performed transorally and confirmed with transcervical dissection. METHODS: Eight color-injected cadaveric heads (16 sides) were dissected to demonstrate the course and anatomy of the glossopharyngeal nerve...
September 2016: Laryngoscope
https://www.readbyqxmd.com/read/27302512/risk-of-severe-toxicity-according-to-site-of-recurrence-in-patients-treated-with-stereotactic-body-radiation-therapy-for-recurrent-head-and-neck-cancer
#11
Diane C Ling, John A Vargo, Robert L Ferris, James Ohr, David A Clump, Wai-Ying Wendy Yau, Umamaheswar Duvvuri, Seungwon Kim, Jonas T Johnson, Julie E Bauman, Barton F Branstetter, Dwight E Heron
PURPOSE: To report a 10-year update of our institutional experience with stereotactic body radiation therapy (SBRT) for reirradiation of locally recurrent head and neck cancer, focusing on predictors of toxicity. METHODS AND MATERIALS: A retrospective review was performed on 291 patients treated with SBRT for recurrent, previously irradiated head and neck cancer between April 2002 and March 2013. Logistic regression analysis was performed to identify predictors of severe acute and late toxicity...
July 1, 2016: International Journal of Radiation Oncology, Biology, Physics
https://www.readbyqxmd.com/read/27225507/utility-of-up-front-transoral-robotic-surgery-in-tailoring-adjuvant-therapy
#12
Neil Gildener-Leapman, Jeehong Kim, Shira Abberbock, Garret W Choby, Rajarsi Mandal, Umamaheswar Duvvuri, Robert L Ferris, Seungwon Kim
BACKGROUND: The purpose of this study was to describe how the up-front transoral robotic surgery (TORS) approach could be used to individually tailor adjuvant therapy based on surgical pathology. METHODS: Between January 2009 and December 2013, 76 patients received TORS for oropharyngeal squamous cell carcinoma (OPSCC). Clinical predictors of adjuvant therapy were analyzed and comparisons were made between recommended treatment guidelines for up-front surgery versus definitive nonsurgical approaches...
August 2016: Head & Neck
https://www.readbyqxmd.com/read/27177865/phase-ii-randomized-trial-of-radiation-therapy-cetuximab-and-pemetrexed-with-or-without-bevacizumab-in-patients-with-locally-advanced-head-and-neck-cancer
#13
A Argiris, J E Bauman, J Ohr, W E Gooding, D E Heron, U Duvvuri, G J Kubicek, D M Posluszny, M Vassilakopoulou, S Kim, J R Grandis, J T Johnson, M K Gibson, D A Clump, J T Flaherty, S I Chiosea, B Branstetter, R L Ferris
BACKGROUND: We previously reported the safety of concurrent cetuximab, an antibody against epidermal growth factor receptor (EGFR), pemetrexed, and radiation therapy (RT) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). In this non-comparative phase II randomized trial, we evaluated this non-platinum combination with or without bevacizumab, an inhibitor of vascular endothelial growth factor (VEGF). PATIENTS AND METHODS: Patients with previously untreated stage III-IVB SCCHN were randomized to receive: conventionally fractionated radiation (70 Gy), concurrent cetuximab, and concurrent pemetrexed (arm A); or the identical regimen plus concurrent bevacizumab followed by bevacizumab maintenance for 24 weeks (arm B)...
August 2016: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://www.readbyqxmd.com/read/27080244/oncologic-outcomes-of-surgically-treated-early-stage-oropharyngeal-squamous-cell-carcinoma
#14
Jason I Kass, Laureano Giraldez, William Gooding, Garret Choby, Seungwon Kim, Brett Miles, Marita Teng, Andrew G Sikora, Jonas T Johnson, Eugene N Myers, Umamaheswar Duvvuri, Eric M Genden, Robert L Ferris
BACKGROUND: The purpose of this study was to characterize oncologic outcomes in early (T1-T2, N0) and intermediate (T1-T2, N1) oropharyngeal squamous cell carcinoma (SCC) after surgery. METHODS: Patients with oropharyngeal SCC treated with surgery were identified from 2 academic institutions. RESULTS: Of 188 patients, 143 met the inclusion criteria. Eighty-six (60%) had T1 to T2 N0 and 57 (40%) had T1 to T2 N1 disease. Sixty-five patients (45%) underwent a robotic-assisted resection, whereas the remaining had transoral (n = 60; 42%), mandible-splitting (n = 11; 8%), or transhyoid approaches (n = 7; 5%)...
October 2016: Head & Neck
https://www.readbyqxmd.com/read/27071529/population-structure-and-drug-resistance-patterns-of-emerging-non-pcv-13-streptococcus-pneumoniae-serotypes-22f-15a-and-8-isolated-from-adults-in-ontario-canada
#15
Venkata R Duvvuri, Xianding Deng, Sarah Teatero, Nader Memari, Taryn Athey, Nahuel Fittipaldi, Jonathan B Gubbay
The introduction of pneumococcal conjugate vaccines has led to the emergence of non-vaccine serotypes, which contributed to invasive pneumococcal disease in Canada and worldwide. A significant increase in the prevalence of non-13-valent pneumococcal conjugate vaccine (PCV-13)-included serotypes 22F, 15A, and 8 was observed from 2009 to 2013 in Ontario (all p values<0.01). In this study, whole genome sequencing was conducted on the 25 isolates of serotype 22F, seven of 15A and 10 of 8 to investigate the population structure and antibiotic resistance...
August 2016: Infection, Genetics and Evolution
https://www.readbyqxmd.com/read/26950771/robotics-in-otolaryngology-and-head-and-neck-surgery-recommendations-for-training-and-credentialing-a-report-of-the-2015-ahns-education-committee-aao-hns-robotic-task-force-and-aao-hns-sleep-disorders-committee
#16
Neil D Gross, F Christopher Holsinger, J Scott Magnuson, Umamaheswar Duvvuri, Eric M Genden, Tamer Ah Ghanem, Kathleen L Yaremchuk, David Goldenberg, Matthew C Miller, Eric J Moore, Luc Gt Morris, James Netterville, Gregory S Weinstein, Jeremy Richmon
Training and credentialing for robotic surgery in otolaryngology - head and neck surgery is currently not standardized, but rather relies heavily on industry guidance. This manuscript represents a comprehensive review of this increasingly important topic and outlines clear recommendations to better standardize the practice. The recommendations provided can be used as a reference by individuals and institutions alike, and are expected to evolve over time. © 2016 Wiley Periodicals, Inc. Head Neck 38: E151-E158...
April 2016: Head & Neck
https://www.readbyqxmd.com/read/26939990/a-20-year-review-of-75-cases-of-salivary-duct-carcinoma
#17
Mark R Gilbert, Arun Sharma, Nicole C Schmitt, Jonas T Johnson, Robert L Ferris, Umamaheswar Duvvuri, Seungwon Kim
IMPORTANCE: Salivary duct carcinoma is a rare, aggressive malignancy of the salivary glands. Owing to its rare nature, clinical data are limited, and only a few clinical studies comprise more than 50 patients. OBJECTIVE: To review the University of Pittsburgh Medical Center's experience with salivary duct carcinoma over a 20-year period, focusing on demographics, presentation, treatment, and outcome. DESIGN, SETTING, AND PARTICIPANTS: This investigation was a retrospective cohort study in a multihospital institution with tertiary referral...
May 1, 2016: JAMA Otolaryngology—Head & Neck Surgery
https://www.readbyqxmd.com/read/26926937/outcomes-of-interventions-for-carotid-blowout-syndrome-in-patients-with-head-and-neck-cancer
#18
Nathan L Liang, Brian D Guedes, Umamaheswar Duvvuri, Michael J Singh, Rabih A Chaer, Michel S Makaroun, Ulka Sachdev
BACKGROUND: The purpose of this study was to examine outcomes of a patient cohort undergoing intervention for carotid blowout syndrome associated with head and neck cancer. METHODS: Patients with head and neck cancer who presented with carotid distribution bleeding from 2000 to 2014 were identified in the medical record. Primary outcomes were short- and midterm mortality and recurrent bleeding. Standard statistical methods and survival analysis were used to analyze study population characteristics and outcomes...
June 2016: Journal of Vascular Surgery
https://www.readbyqxmd.com/read/26925577/first-in-human-safety-and-long-term-exposure-data-for-aab-003-pf-05236812-and-biomarkers-after-intravenous-infusions-of-escalating-doses-in-patients-with-mild-to-moderate-alzheimer-s-disease
#19
Marielle Delnomdedieu, Sridhar Duvvuri, David Jianjun Li, Nazem Atassi, Ming Lu, H Robert Brashear, Enchi Liu, Seth Ness, James W Kupiec
BACKGROUND: In the First-In-Human (FIH), 39-week, randomized, adaptive design study, safety, tolerability, pharmacokinetics and biomarkers were measured in patients with mild-to-moderate Alzheimer's disease (AD) after infusion of a humanized monoclonal antibody to amyloid β, AAB-003 (NCT01193608; registered 19 August 2010). AAB-003 was developed by modifying bapineuzumab to reduce Fc-receptor-mediated effector function as a strategy to reduce the removal of amyloid from vessel walls associated with amyloid-related imaging abnormalities with edema/effusions (ARIA-E) without diminishing overall amyloid clearance...
2016: Alzheimer's Research & Therapy
https://www.readbyqxmd.com/read/26862022/hyalinizing-clear-cell-carcinoma-with-biopsy-proven-spinal-metastasis-case-report-and-review-of-literature
#20
William C Newman, Lindsay Williams, Umamaheswar Duvvuri, David A Clump, Nduka Amankulor
BACKGROUND: Hyalinizing clear cell carcinoma (HCCC) is a rare epithelial malignant neoplasm typically arising from the minor salivary glands. Although it has been described as a benign neoplasm, there are increasing reports of malignant features and metastases to the lungs; we present the first case of biopsy-proven spinal metastases from HCCC and an overview of the literature. CASE DESCRIPTION: This is a single-patient case report in which we used immunohistochemistry and fluorescence in situ hybridization for Ewing sarcoma breakpoint region 1 translocation to confirm the diagnosis of HCCC in a spinal metastasis...
June 2016: World Neurosurgery
keyword
keyword
32877
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"